Consensus DarioHealth Corp.

Equities

DRIO

US23725P2092

Market Closed - Nasdaq Other stock markets 04:00:00 2024-04-26 pm EDT			5-day change	1st Jan Change
1.48 ^USD	+0.68%		+27.59%	-13.95%

Apr. 25	DarioHealth Corp. Publishes New Peer-Reviewed Study That Deepens the Body of Evidence That Managing Cardiometabolic Conditions in One Integrated Platform Improves Clinical Outcomes	CI
Apr. 18	DarioHealth Corp. Signs Two Employers for Cardiometabolic Suite with Integrated Glp-1 Solution	CI

Evolution of the average Target Price on DarioHealth Corp.

Price target over the last 5 years

History of analyst recommendation changes

94385865d088ea7fe5e6949f0a9b4fad.f0YvhgxoU1-9dpBl3DEoWySTYYa4aH8-HTuesBcBwTc.KzddtGMuYTjlGvM8tXJ-PkiiL7bBEB5xU0z21GRF9w4YGUbQTRoKKYw-qA~87c75fefcdf34557f1832416391e83ab

Analyst Recommendations on DarioHealth Corp.

Alliance Global Adjusts Price Target on DarioHealth to $4.10 From $5.45, Keeps Buy Rating	23-08-11	MT
Stifel Nicolaus Adjusts DarioHealth Price Target to $6 From $9, Maintains Buy Rating	23-07-25	MT
Craig-Hallum Adjusts DarioHealth's Price Target to $8 From $14, Keeps Buy Rating	23-05-12	MT
Alliance Global Partners Adjusts Price Target on DarioHealth to $7.50 From $9.15, Maintains Buy Rating	22-11-16	MT
Aegis Capital Adjusts DarioHealth's Price Target to $15 from $20, Keeps Buy Rating	22-08-18	MT
Stifel Nicolaus Adjusts DarioHealth Price Target to $11 From $15, Maintains Buy Rating	22-08-16	MT
Cowen Adjusts Trims Price Target on DarioHealth to $14 From $18, Keeps Outperform Rating	22-08-16	MT
Craig-Hallum Lowers Price Target for DarioHealth to $14 From $18, Maintains Buy Rating	22-08-15	MT
Aegis Capital Adjusts DarioHealth's Price Target to $20 from $23, Keeps Buy Rating	22-05-16	MT
Cowen Adjusts DarioHealth's Price Target to $18 from $14, Keeps Outperform Rating	22-05-16	MT
Alliance Global Upgrades DarioHealth to Buy From Neutral, Keeps $8.75 Price Target	22-05-13	MT
Aegis Capital Adjusts DarioHealth Price Target to $25 From $28, Maintains Buy Rating	22-01-26	MT
DARIOHEALTH : Aegis Capital Adjusts Price Target on DarioHealth to $28 From $35, Maintains Buy Rating	21-08-19	MT
DARIOHEALTH : Cantor Fitzgerald Adjusts DarioHealth's Price Target to $30 from $35, Keeps Overweight Rating	21-08-17	MT
DARIOHEALTH : Alliance Global Adjusts DarioHealth's Price Target to $12.75 From $15.25, Maintains Neutral Rating	21-08-17	MT
DARIOHEALTH : Alliance Global Adjusts DarioHealth's Price Target to $15.25 From $18.25, Maintains Neutral Rating	21-05-24	MT
DARIOHEALTH : Cowen Starts DarioHealth at Outperform With $31 Price Target	21-04-22	MT
DARIOHEALTH : Stifel Starts DarioHealth at Buy With $30 Price Target	21-03-23	MT
DARIOHEALTH : Cantor Fitzgerald Starts DarioHealth at Overweight With $35 Price Target	21-02-25	MT
DARIOHEALTH : Alliance Global Partners Downgrades DarioHealth to Neutral From Buy, Adjusts PT to $22.25 From $15.60	21-02-01	MT